MS Virtual 2020

8th Joint ACTRIMS and ECTRIMS Meeting

No new safety signals in ofatumumab open-label data

Low-dose rituximab as effective as high-dose, but safer

Induction more effective than escalation as strategy in RRMS

Management of PPMS and SPMS with approved DMT

Amantadine, modafinil, and methylphenidate for MS-related fatigue

Predictive value of neurodegenerative CSF markers in MS

Masitinib possible new treatment of progressive MS

Gender-based approach to MS therapeutics: a missed opportunity

Eculizumab reduces long-term relapse risk in AQP4+ NMOSD

Cardiovascular risk factors linked to brain atrophy in younger MS patients

Gold nanocrystals may improve brain metabolic profile

Functional potential of gut microbiome in paediatric MS

Top image: @ iStockPhoto: wildpixel

The content and interpretation of these conference highlights are the views and comments of the speakers/ authors.